Aditya Kumar | Genomics | Best Researcher Award

Published-on by Indian Scientist

Dr. Aditya Kumar | Genomics | Best Researcher Award

Tezpur University, India

Author Profile

Early Academic Pursuits 🎓

Aditya Kumar’s journey in the field of Molecular Biology and Biotechnology began with an enduring commitment to education and scientific discovery. He pursued a PhD from the prestigious Indian Institute of Science (IISc) in Bangalore, specializing in the Molecular Biophysics Unit from July 2008 to December 2015. This was a formative period where Aditya honed his technical skills, gained in-depth knowledge of molecular biophysics, and conducted research with an emphasis on understanding molecular interactions at a structural and biochemical level. His experience at IISc positioned him for a robust scientific career, fostering a foundation in molecular sciences that prepared him for future roles in academia and research.Following his PhD, Aditya continued at IISc as a Research Associate from January 2016 to March 2017. This postdoctoral experience enabled him to deepen his expertise in molecular biophysics, contributing to advanced projects and collaborating with other experts in the field. During this time, Aditya refined his skills in biomolecular analysis and structural studies. The meticulous training and innovative research methods he acquired at IISc set him on a path for academic distinction.

Professional Endeavors at Tezpur University 🏫

In April 2017, Aditya Kumar joined Tezpur University in Napaam, Assam, as an Assistant Professor in the Department of Molecular Biology and Biotechnology. This role marked a significant milestone in Aditya’s career, as he transitioned from research associate to professor, taking on responsibilities that included teaching, mentoring, and leading research projects. At Tezpur University, he has developed courses that focus on biotechnology fundamentals, molecular biology, and biophysics, aiming to inspire and equip students with the necessary skills for modern biological research.Beyond classroom teaching, Aditya has been active in organizing seminars, workshops, and conferences to expose students and fellow researchers to the latest advancements in biotechnology. His tenure at Tezpur University reflects his dedication to scientific education and innovation, and his focus on shaping the next generation of molecular biologists. As a faculty member, he has emphasized hands-on training in laboratory techniques and promoted research-based learning, fostering an academic environment where students can explore, question, and understand complex biological processes.

Contributions and Research Focus 🔬

Throughout his career, Aditya Kumar has contributed to numerous research projects in molecular biology, structural biophysics, and biotechnology. His research interests include studying protein-protein interactions, enzyme mechanisms, and structural dynamics of biomolecules, which are critical in understanding the fundamental processes of life at a molecular level. His work at IISc and Tezpur University reflects a dedication to discovery-driven research that could pave the way for innovative solutions in fields such as drug design, biotechnology, and environmental biology.Aditya has published his findings in several respected scientific journals and has presented his research at national and international conferences, contributing to the broader scientific community’s understanding of molecular mechanisms. His work has advanced knowledge in areas such as enzyme kinetics, protein folding, and cellular signaling pathways, addressing some of the most challenging questions in molecular biology. These contributions are not only valuable for academic purposes but also have potential applications in developing new therapeutic interventions.

Accolades and Recognition 🏆

Aditya Kumar’s dedication to excellence in research and teaching has not gone unnoticed. He has received numerous accolades throughout his career, recognizing his academic achievements, research contributions, and commitment to student mentorship. His contributions to molecular biophysics have earned him a respected place in the scientific community, where he is known for his innovative approaches to research and his ability to explain complex concepts in an accessible way.At Tezpur University, he has been appreciated for his student-centric approach and his efforts in making biotechnology and molecular biology engaging and accessible. Aditya’s dedication to both academic and research excellence exemplifies his commitment to advancing molecular science, and his work continues to garner respect from colleagues and students alike.

Impact and Influence 🌍

Aditya Kumar’s work has had a far-reaching impact, particularly in the fields of molecular biology and biotechnology. His research has contributed to our understanding of molecular interactions and biophysical processes that are essential for advancing biotechnological applications. In the classroom, Aditya’s influence is evident in the success and achievements of his students, many of whom have gone on to pursue advanced studies and careers in molecular biology.As a mentor and researcher, Aditya has inspired a generation of students at Tezpur University to pursue scientific discovery and innovation. His approach to teaching emphasizes critical thinking and problem-solving, encouraging students to think beyond the textbook and apply their knowledge to real-world challenges. His influence extends beyond academia as well, as his research contributes to biotechnological advancements that benefit society, potentially influencing developments in areas such as medicine, agriculture, and environmental sustainability.

Legacy and Future Contributions 🌟

Looking forward, Aditya Kumar aims to continue his work in molecular biophysics and biotechnology, with a focus on advancing our understanding of molecular systems. His future projects include exploring novel molecular pathways and their potential applications in healthcare and environmental science. Aditya is also committed to enhancing research facilities and educational programs at Tezpur University, aiming to establish the institution as a leading center for biotechnological research in India.Aditya’s career reflects a legacy of dedication to scientific discovery and academic mentorship. His contributions have already left a mark on the field of molecular biology, and his ongoing work promises to further expand our understanding of life at a molecular level. As he continues his journey, Aditya’s influence on his students, colleagues, and the broader scientific community will undoubtedly grow, cementing his legacy as a pioneering researcher and dedicated educator in biotechnology and molecular sciences.

Citations

A total of 304 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        304
  • h-index          35
  • i10-index       9

Notable Publications 

  • Title: Anti-tumor potential of high salt in breast Cancer cell lines
    Authors: Sharma, M., Dey, U., Das, A.S., Kumar, A., Mukhopadhyay, R.
    Journal: Molecular Biology Reports
    Year: 2024.
  • Title: Unravelling the genomic secrets of bacterial fish pathogens: a roadmap to aquaculture sustainability
    Authors: Olymon, K., Yadav, M., Teronpi, V., Kumar, A.
    Journal: Molecular Biology Reports
    Year: 2024.
  • Title: Discerning the Role of DNA Sequence, Shape, and Flexibility in Recognition by Drosophila Transcription Factors
    Authors: Murthy, S., Dey, U., Olymon, K., Yella, V.R., Kumar, A.
    Journal: ACS Chemical Biology
    Year: 2024.
  • Title: Adipose tissue macrophage–derived microRNA-210-3p disrupts systemic insulin sensitivity by silencing GLUT4 in obesity
    Authors: Patra, D., Ramprasad, P., Sharma, S., Tikoo, K., Pal, D.
    Journal: Journal of Biological Chemistry
    Year: 2024.
  • Title: Navigating the signaling landscape of Ralstonia solanacearum: a study of bacterial two-component systems
    Authors: Yadav, M., Sathe, J., Teronpi, V., Kumar, A.
    Journal: World Journal of Microbiology and Biotechnology
    Year: 2024.

Nethaji Muniraj | Cell therapy | Best Research Award

Published-on by Indian Scientist

Dr. Nethaji Muniraj | Cell therapy | Best Research Award

Children’s National Hospital, Washington DC, India

Author Profile

Early Academic Pursuits 🎓

Nethaji Muniraj’s academic journey showcases a deep-rooted passion for biochemistry and molecular medicine. He began his higher education in India, earning a Bachelor of Science in Biochemistry from the University of Madras between 1996 and 1999. His undergraduate studies provided him with a solid foundation in subjects like bio-organic chemistry, intermediary metabolism, analytical methods, physiology, and clinical biochemistry. This early focus on understanding the biochemical processes within living organisms set the stage for his later work in molecular medicine and cancer research.Driven by his thirst for knowledge and a commitment to advancing medical science, Muniraj pursued a Master of Science in Medical Biochemistry at the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) under Pondicherry University from 1999 to 2002. His coursework spanned diverse subjects such as human anatomy, physiology, cell and molecular biology, endocrinology, and clinical biochemistry. These early academic years equipped him with a comprehensive understanding of the intricate biochemical processes underlying human health and disease.Building on his strong academic foundation, Muniraj embarked on his most significant academic achievement — a PhD in Molecular Medicine from the prestigious Liggins Institute at the University of Auckland, New Zealand (2007-2012). His PhD thesis, titled Molecular Characterization of Trefoil Factor 1 (TFF1) in Gastric Carcinoma Cells, highlighted his emerging expertise in cancer biology. The research involved identifying molecular mechanisms in gastric carcinoma, contributing to the growing field of cancer therapeutics. This pivotal phase of his academic career cemented his future direction in cancer research and molecular medicine.

Professional Endeavors 🌍

Nethaji Muniraj’s professional career has been a global journey across continents, underscoring his determination to apply his expertise to various challenging roles. His work experience began in India as a Junior Research Fellow at Shriram Institute for Industrial Research, Bangalore (2002-2005), where he focused on applied biochemical research. He further deepened his research experience by serving as a Junior Research Fellow at the National Institute of Animal Nutrition and Physiology (NIANP), Bangalore from 2012 to 2013. During this period, Muniraj gained invaluable experience in research methodologies, laboratory techniques, and data analysis, enhancing his ability to conduct cutting-edge scientific research.His international research career took off with a series of prestigious positions in New Zealand. Muniraj worked as an Assistant Research Fellow at the University of Otago, first in the Department of Pathology (2013-2014) and then in the Department of Microbiology & Immunology (2014). These roles allowed him to explore various immunological and pathological aspects of diseases, particularly focusing on cancer.Muniraj’s journey reached a significant milestone when he joined the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, USA, in 2014 as a Postdoctoral Research Fellow. Over the next seven years (2014-2021), he delved deeper into oncology research, investigating novel cancer treatments and contributing to the fight against this devastating disease. His research at one of the world’s most renowned cancer centers solidified his standing as a leading figure in cancer immunology and therapeutic research.Currently, Muniraj holds the position of Staff Scientist-I at Children’s National Hospital’s Center for Cancer and Immunology Research (CCIR), Washington, DC, USA, where he continues his groundbreaking work in cancer immunology, focusing on translational research to develop therapies for childhood cancers.

Contributions and Research Focus 🔬

Nethaji Muniraj’s research focus has been deeply intertwined with cancer biology and immunology, particularly in the context of developing novel therapeutic approaches. His PhD thesis on Trefoil Factor 1 (TFF1) in gastric carcinoma cells contributed to a better understanding of how TFF1, a protein involved in mucosal protection, plays a role in cancer progression. This work helped pave the way for future research into the mechanisms underlying gastric cancer, an area of significant global health concern.At Johns Hopkins University, Muniraj expanded his research to explore oncology, working on various cancer models and understanding the molecular mechanisms that contribute to tumor development, growth, and metastasis. His research in cancer immunology aimed to harness the body’s immune system to combat cancer, leading to potential advances in immunotherapy treatments. His contributions in this field are aligned with the broader movement towards more personalized and effective cancer therapies.Muniraj’s current work at Children’s National Hospital continues this trajectory, with a focus on pediatric cancers. His research integrates molecular biology, immunology, and clinical science, striving to develop more targeted therapies for young patients with cancer. This cutting-edge research aims to revolutionize cancer treatment by minimizing side effects and improving survival rates among children.

Accolades and Recognition 🏆

Throughout his illustrious career, Nethaji Muniraj has garnered significant recognition for his contributions to molecular medicine and cancer research. His PhD work at the University of Auckland earned him accolades within the academic community, and his subsequent positions at prestigious institutions such as Johns Hopkins University and Children’s National Hospital speak volumes about his reputation in the field.In addition to his professional roles, Muniraj has contributed to numerous peer-reviewed journals, further enhancing his reputation as an authority in cancer research. His collaborative work across the globe, particularly in the fields of immunology and oncology, has placed him among the influential voices in translational cancer research.

Impact and Influence 🌟

Nethaji Muniraj’s research has had a far-reaching impact, particularly in the realm of cancer treatment and immunotherapy. His contributions to understanding the molecular mechanisms of cancer and the role of the immune system in combating the disease have opened new avenues for therapeutic interventions. Muniraj’s work has influenced both his peers and future generations of researchers, contributing to the global effort to develop more effective cancer treatments.His role as a mentor and researcher has also helped shape the next generation of scientists, guiding them towards impactful careers in biochemistry, molecular medicine, and cancer research. His presence in leading cancer research institutions such as Johns Hopkins and Children’s National Hospital underscores his influential role in shaping the future of cancer therapy.

Legacy and Future Contributions 🌍✨

Nethaji Muniraj’s legacy lies in his tireless dedication to advancing cancer research, particularly in the realm of immunotherapy and molecular medicine. His work continues to inspire new research directions, particularly in the fight against pediatric cancers. With his continued efforts at Children’s National Hospital, Muniraj is poised to make even greater contributions to science, offering hope to countless individuals affected by cancer worldwide.Looking ahead, Muniraj’s future contributions will likely focus on further refining immunotherapy techniques and translating molecular research into clinical applications. His legacy will be one of innovation, perseverance, and dedication to improving human health through scientific discovery.

Citations

A total of 1036 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         1036
  • h-index           16
  • i10-index        18

Notable Publications 

  • Title: ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis
    Authors: SJ Chung, GP Nagaraju, A Nagalingam, N Muniraj, P Kuppusamy, …
    Journal: Autophagy, Volume 13, Issue 8, Pages 1386-1403
    Year: 2017.
  • Title: A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and β-catenin axes
    Authors: S Parida, S Wu, S Siddharth, G Wang, N Muniraj, A Nagalingam, C Hum, …
    Journal: Cancer Discovery, Volume 11, Issue 5, Pages 1138-1157
    Year: 2021.
  • Title: Regulation of chemokines and cytokines by histone deacetylases and an update on histone deacetylase inhibitors in human diseases
    Authors: HR Gatla, N Muniraj, P Thevkar, S Yavvari, S Sukhavasi, MR Makena
    Journal: International Journal of Molecular Sciences, Volume 20, Issue 5, Article 1110
    Year: 2019.
  • Title: Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3
    Authors: S Sengupta, A Nagalingam, N Muniraj, MY Bonner, P Mistriotis, A Afthinos, …
    Journal: Oncogene, Volume 36, Issue 41, Pages 5709-5721
    Year: 2017.
  • Title: Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells
    Authors: N Amiry, X Kong, N Muniraj, N Kannan, PM Grandison, J Lin, Y Yang, …
    Journal: Endocrinology, Volume 150, Issue 10, Pages 4473-4483
    Year: 2009.

Prasad Neerati | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Prof. Prasad Neerati | Pharmacology | Best Researcher Award

Kakatiya University, India

Author Profile

Early Academic Pursuits 🏫

Prof. Neerati Prasad’s academic journey began with a solid foundation in the sciences. He completed his Secondary School Certificate (SSC) in 1991 with a first-class division, securing 74.16% marks. His thirst for knowledge continued as he excelled in his Intermediate studies, achieving 89.53% in 1994 under the Board of Technical Education. His academic journey took a decisive turn when he pursued his undergraduate degree at Kakatiya University, Warangal, where he graduated in 1999 with 65.80% marks. His passion for pharmaceutical sciences grew stronger during his postgraduate studies, also at Kakatiya University, where he emerged as a University Topper 🏆 in 2002, with a distinction and a remarkable 75.50%.Prof. Prasad’s pre-PhD academic qualifications were equally impressive, as he continued his studies at Kakatiya University, securing 70.1% marks in 2007. This solid academic grounding paved the way for his remarkable research career.

Professional Endeavors 👨‍🏫

With 16 years of experience teaching postgraduate (P.G.) classes and 18 years of undergraduate (U.G.) teaching, Prof. Neerati Prasad has been a pillar in the academic world. His dedication to nurturing young minds and guiding them toward excellence is evident in his long-standing role as a professor at Kakatiya University.Beyond teaching, Prof. Prasad’s research contributions have been extensive. He has spent 15 years in research, excluding the years dedicated to his M.Phil. and Ph.D. studies. His research interests are diverse and impactful, spanning Clinical Pharmacokinetics, Drug Transport, Pharmacokinetics and Drug Metabolism, Cancer Metastasis (with a focus on the role of phyto-polyphenols), Toxicological Studies, and the Pharmacological Screening of new chemical entities from natural sources 🌿. These fields of research hold immense significance for the development of novel therapeutic agents, making his work critical for both academia and the pharmaceutical industry.

Contributions and Research Focus 🔬

Prof. Neerati Prasad’s research has been groundbreaking in several key areas. During his M.Pharm., he conducted an insightful study on Bacteremia amongst Leprosy Patients, awarded in June 2002. However, his most notable work came during his Ph.D., where he explored the Isolation and Characterization of probable potential pharmacological agents from animals and their waste. This innovative research, completed in 2007, opened new avenues in pharmacological studies, contributing to the understanding of natural pharmacological agents.Prof. Prasad’s international experience includes his Post-Doctoral Fellowship (PDF) at SRI International in California, USA 🌍. There, he conducted advanced research in Tumor Glycomics, focusing on biomarker discovery, tumor targeting agents, and the regulation of metastasis by endogenous angioinhibitors. His work at the intersection of pharmacology and cancer research has contributed to a better understanding of metastasis and cancer treatment, positioning him as a key researcher in the field of oncology.

Accolades and Recognition 🏅

Prof. Prasad’s academic and research excellence has not gone unnoticed. He is a recipient of the prestigious C.V. Raman Fellowship, awarded by the University Grants Commission (UGC). This fellowship is given to distinguished scholars to encourage high-quality research. Additionally, during his Ph.D. journey, he was awarded a UGC Research Fellowship for his exceptional work. These accolades reflect not only his dedication to the field but also the high regard in which he is held by the academic community.

Impact and Influence 🌍

Prof. Neerati Prasad’s work has had a profound impact on the fields of pharmacology, oncology, and pharmaceutical sciences. His research on Cancer Metastasis and the role of natural compounds in regulating metastasis has been instrumental in developing new approaches to cancer treatment. Moreover, his contributions to Clinical Pharmacokinetics and Drug Metabolism have helped shape the development of safer and more effective drugs.His teaching has influenced countless students who have gone on to pursue successful careers in pharmacy and related fields. Through his mentorship, he has cultivated a generation of researchers and professionals who continue to contribute to the pharmaceutical sciences. His dedication to both teaching and research makes him a well-rounded academic whose influence is felt both inside and outside the classroom. 🎓

Legacy and Future Contributions 🌟

As a seasoned academic and researcher, Prof. Neerati Prasad’s legacy in the field of pharmaceutical sciences is already well-established. However, his journey is far from over. With a continued focus on cutting-edge research in Tumor Glycomics, Drug Transport, and Cancer Metastasis, his work holds the promise of further breakthroughs in these critical areas of healthcare. His research on the Pharmacological Screening of New Chemical Entities from Natural Sources is likely to lead to the discovery of novel therapeutic agents, offering new hope for the treatment of various diseases.In the years to come, Prof. Prasad’s influence will continue to grow as he inspires future generations of pharmacists and researchers. His commitment to advancing pharmaceutical sciences, both in India and internationally, ensures that his contributions will leave a lasting legacy. 🌍

Citations

A total of 667 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         667
  • h-index           41
  • i10-index        16

Notable Publications 

  • Title: A New Epoxy Steroid Isolated and Characterized from Bufo melanostictus Venom with Potential IL-6 along with TNF-α Inhibition and Spectroscopic Study for Structure and Vibrational Properties Using DFT
    Authors: Bonagani, N., Neerati, P., Prashanth, J., Byru, V.R.
    Journal: Journal of Molecular Structure
    Year: 2024.
  • Title: Hypoxia and Extracellular Matrix – Major Drivers of Tumor Metastasis
    Authors: Neerati, P., Polati, D.
    Journal: Hypoxia in Cancer: Significance and Impact on Cancer Therapy (Book Chapter)
    Year: 2023.
  • Title: Novel Indole Derivative as the First P-glycoprotein Inhibitor from the Skin of Indian Toad (Bufo melanostictus)
    Authors: Neerati, P., Munigadapa, S.
    Journal: Turkish Journal of Pharmaceutical Sciences
    Year: 2022.
  • Title: A New Steroidal Derivative from the Skin of Indian Toad (Bufo melanostictus) as a Hypolipidemic and CYP 3A Inhibitor
    Authors: Munigadapa, S.K., Neerati, P.
    Journal: Tropical Journal of Pharmaceutical Research
    Year: 2022.
  • Title: Gallic Acid Improved Amytryptiline Effect in Neuropathic Pain Induced by Partial Sciatic Nerve Ligation (Psnl) in Rats
    Authors: Neerati, P., Enumula, V.
    Journal: Natural Products Journal
    Year: 2021.

PRANJAL GUJARATHI | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Dr. PRANJAL GUJARATHI | Pharmacology | Best Researcher Award

Vidhyadeep Institute of Pharmacy, Vidhyadeep Univeirsty,Surat India

Author Profile

Early Academic Pursuits 🎓📚

Pranjal Gujarathi’s academic journey in pharmacology began with a deep-rooted interest in the sciences. He pursued a focused path in pharmacy and pharmacology, equipping himself with the knowledge necessary to excel in drug research, pharmacodynamics, and pharmacokinetics. His formal education laid the foundation for his future contributions in understanding drug mechanisms and their effects on biological systems. His commitment to academic excellence ensured that he built a strong grounding in pharmacological principles, which later translated into valuable insights in the field of drug discovery and therapeutic innovations.

Professional Endeavors 🧑‍🔬👨‍🏫

Pranjal Gujarathi has had an impactful professional career in pharmacology, spanning teaching and research roles. He began his professional journey as an Assistant Professor of pharmacology at Shree Dhanvantry Pharmacy College in Surat, Gujarat, from July 27, 2017, to May 15, 2021. During his tenure, Pranjal played a pivotal role in mentoring students, designing course curricula, and advancing the department’s research objectives. His teaching covered various aspects of pharmacology, from drug development to therapeutic applications, helping shape the next generation of pharmacists and pharmacologists.In February 2022, Pranjal transitioned into a Junior Research Fellow position at the same institution, a role that allowed him to dive deeper into pharmacological research. His current work focuses on exploring novel drug therapies, pharmacogenomics, and the development of more effective and safer medications. This shift from teaching to dedicated research underscores his versatility and his dedication to pushing the boundaries of pharmacological knowledge.

Contributions and Research Focus 🔬💉

Pranjal Gujarathi’s research has primarily revolved around drug discovery, preclinical studies, and pharmacodynamics, areas where he has made significant contributions. His work emphasizes the understanding of drug-receptor interactions, drug metabolism, and toxicology, all of which are crucial in the early stages of drug development. His role as a Junior Research Fellow allows him to collaborate with other scientists to test the efficacy and safety of new drug formulations before they enter clinical trials.His research is also centered on immunopharmacology and neuropharmacology, focusing on conditions like psoriasis and neurodegenerative diseases. These diseases represent significant challenges in pharmacotherapy, and Pranjal’s preclinical work has helped pave the way for potential breakthroughs in treatment. His expertise in pharmacokinetics, which studies how drugs move through the body, further enhances the precision of his research, allowing for more targeted and effective treatments.

Accolades and Recognition 🏆📜

Pranjal Gujarathi has been widely recognized for his contributions to pharmacology. His research has been published in esteemed journals such as International Immunopharmacology and Naunyn-Schmiedeberg’s Archives of Pharmacology. These publications highlight his growing influence in the scientific community, particularly in the areas of drug discovery in psoriasis and comprehensive studies on Hypericum perforatum in treating neurodegenerative diseases.His academic prowess and ability to translate complex pharmacological concepts into applied research have earned him accolades at conferences and symposia, where his papers have been well-received. These recognitions validate his dedication to advancing the field of pharmacology and underscore his commitment to improving public health through better pharmaceuticals.

Impact and Influence 🌍💊

Pranjal’s influence extends beyond the confines of academia and research. As an educator, he has inspired countless students to pursue careers in pharmacology, instilling in them a rigorous understanding of drug mechanisms and their therapeutic uses. His role in preclinical research has contributed to the development of safer, more effective drugs, influencing the way treatments for chronic diseases like psoriasis are approached.His research on the pharmacological properties of natural products like Hypericum perforatum has opened new avenues in understanding plant-based therapies, potentially offering more accessible and less invasive treatment options for complex conditions. This focus on both synthetic and natural compounds ensures that his work remains relevant across a broad spectrum of pharmacology.

Legacy and Future Contributions 🚀🔝

As Pranjal Gujarathi continues his journey in pharmacological research, his contributions are likely to have a lasting impact on the field. His focus on innovative drug therapies, coupled with his dedication to teaching, positions him as a significant figure in both the academic and scientific communities. His legacy will be defined not only by the drugs developed under his research but also by the knowledge and inspiration he imparts to his students and colleagues.Looking forward, Pranjal is set to make further strides in drug safety evaluations, exploring new territories in personalized medicine and pharmacovigilance. His work has the potential to revolutionize how we understand drug interactions and their effects on different populations, leading to more personalized and effective treatments for patients around the world.

Conclusion 🌟👨‍⚕️

Pranjal Gujarathi’s journey in pharmacology is a testament to his dedication, intellect, and passion for the field. From his early academic pursuits to his significant professional contributions, he continues to influence the development of new drugs and therapies, pushing the boundaries of what’s possible in pharmacological research. With a future that promises even more innovations, Pranjal’s work is sure to leave a lasting legacy in the realm of pharmaceutical sciences.

Notable Publications 

  • Title: Preclinical techniques for drug discovery in psoriasis
    Authors: Gujarathi, P.P., Korat, R.H., Gujarathi, P.S.
    Journal: International Immunopharmacology
    Year: 2024.
  • Title: Hypericum perforatum: A comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases
    Authors: Suryawanshi, M.V., Gujarathi, P.P., Mulla, T., Bagban, I.
    Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
    Year: 2024.
  • Title: Evaluation of acute intravenous toxicity of HEPES: Is Good’s buffer good and safe enough for clinical utilization in nuclear medicine?
    Authors: Guleria, M., Pallavi, K.J., Gujarathi, P.P., Das, T.
    Journal: Nuclear Medicine and Biology
    Year: 2024.

Manish Pal Singh | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Dr. Manish Pal Singh | Pharmacology | Best Researcher Award

Sharda School of Pharmacy, Sharda University, Agra-India

Author Profile

Early Academic Pursuits 🎓

Dr. Manish Pal Singh embarked on his academic journey with a passion for pharmacology. He earned his Bachelor of Pharmacy degree in June 2006 from Rajiv Academy for Pharmacy, Mathura, affiliated with Uttar Pradesh Technical University, Lucknow, where he achieved 64%. Building on his foundation, Dr. Singh pursued his Master of Pharmacy in Pharmacology from B.N. College of Pharmacy, Udaipur. His dedication to academic excellence was evident when he graduated in December 2008 with 73%. His thirst for knowledge didn’t stop there; he went on to achieve his Ph.D. in Pharmacology from the Faculty of Pharmaceutical Sciences, Bhupal Nobles University, Udaipur, completing his doctorate in March 2020.

Professional Endeavors 🧑‍🔬

Dr. Manish Pal Singh’s professional career is marked by his leadership and expertise in pharmacology. His role as a researcher and educator has been pivotal in shaping the future of aspiring pharmacists. His guidance and supervision of numerous Ph.D. and postgraduate projects reflect his commitment to nurturing young minds in the field. Notable among these are projects that explore topics like myocardial infarction, anticonvulsant activity, anti-inflammatory compounds, type 2 diabetes, and wound healing.With his in-depth knowledge of pharmacology, Dr. Singh has successfully supervised numerous Ph.D. scholars and postgraduate students, including Mr. Soumyadip Mukherjee, working on myocardial infarction, Ms. Varsha Snehi on anticonvulsant activities, and Mr. Hritik Verma on anti-inflammatory potential of heterocyclic compounds.

Contributions and Research Focus 🧑‍🏫

Dr. Singh’s research primarily focuses on the pharmacological evaluation of novel compounds, drug synthesis, and exploring the medicinal properties of natural substances. Some of his notable work includes evaluating Launea sarmentosa for Type 2 Diabetes Mellitus (T2DM) and studying the antioxidant and antibacterial properties of Shorea Robusta Resin.He has also supervised research on plants like Amaranthus polygamus for anti-diabetic properties and conducted significant work on stress models in rats using compounds like Vitis Vinifera and Withania Somnifera. His research extends to wound healing, diabetes management, and the exploration of pharmacological potential in various medicinal plants.

Accolades and Recognition 🏅

Dr. Singh’s contributions to the field of pharmacology have been recognized through various grants and awards. He has been honored with two significant grants from the DST (SERB), New Delhi, for organizing conferences and seminars, receiving INR 100,000 in both 2019 and 2022. His academic excellence during his M.Pharm was acknowledged with appreciation certificates across multiple semesters, underlining his dedication and leadership in his field.Moreover, Dr. Singh has published extensively in both national and international journals. His impressive publication record includes 42 articles (21 research papers and 21 review articles) and 27 articles indexed in Scopus and SCI/ESCI. He has also contributed 7 book chapters and presented his research in 21 posters and 5 oral presentations at various conferences.

Impact and Influence 💡

Dr. Singh’s research has a significant impact, with his Google Scholar citations reaching 573 and an H-index of 14. His i10-index stands at 15, indicating the high quality and influence of his research work in the academic community. Additionally, his Scopus H-index is 5, further demonstrating his contributions to the global scientific discourse.His work on pharmacological instruments and animal modeling has equipped him with the practical skills necessary for cutting-edge research. Dr. Singh is also well-versed in documentation processes for NAAC, PCI, and BOS, which has proven beneficial in managing academic and research programs.

Legacy and Future Contributions 🌟

Dr. Manish Pal Singh is not only shaping the present but also influencing the future of pharmacology. His leadership in project coordination and his positive approach to decision-making make him a valuable mentor to his students and colleagues. As he continues to guide doctoral and postgraduate research, Dr. Singh’s contributions will have a lasting impact on pharmacological research, both in India and internationally.Through his work on biological screening of drugs, virtual experimental pharmacological screening, and his hands-on experience with sophisticated pharmacological instruments, Dr. Singh ensures that his students are well-prepared for the future of research and innovation.

Citations

A total of 110 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        110
  • h-index           22
  • i10-index        5

Notable Publications 

  • Pharmacological update on Benincasa Hispida (Thunb.): A review
    • Authors: Singh, S., Gohil, K.J., Singh, M.P.
    • Journal: Pharmacological Research – Modern Chinese Medicine
    • Year: 2024.
  • Phytochemical and pharmacological aspects of genus Amaranthus
    • Authors: Singh, M.P., Goel, B., Kumar, R., Rathor, S.
    • Journal: Fitoterapia
    • Year: 2024.
  • Review on pharmacological activities of Justicia Gendarussa Burm F.
    • Authors: Jain, T., Singh, M.P., Bhardwaj, H., Gohil, K.J.
    • Journal: Pharmacological Research – Modern Chinese Medicine
    • Year: 2024.
  • Therapeutic Role of Desmodium Species on its Isolated Flavonoids
    • Authors: Singh, V., Singh, R., Singh, M.P., Katrolia, A.
    • Journal: Current Molecular Medicine
    • Year: 2024.
  • Autoimmunity and inflammation
    • Authors: Kumar, A., Chawla, V., Chawla, P.A., Singh, M.P., Singh, G.
    • Journal: Recent Developments in Anti-Inflammatory Therapy
    • Year: 2023.

Kudsiya Ashrafi | Biotechnology | Best Researcher Award

Published-on by Indian Scientist

Ms. Kudsiya Ashrafi | Biotechnology | Best Researcher Award

Jamia Hamdard, New Delhi, India

Author Profile

📚Early Academic Pursuits

Kudsiya Ashrafi began her academic journey with a deep passion for biotechnology, enrolling in the Master of Science program at JNVU, Jodhpur. Graduating with distinction, her academic excellence set the stage for a distinguished career in plant biotechnology. Following her M.Sc., she pursued a Ph.D. in Plant Biotechnology at Jamia Hamdard, New Delhi, where her research focused on the development of transgenic varieties of medicinal plants. Her foundational knowledge in genetics, molecular biology, and transgenic technology laid a strong groundwork for her subsequent professional endeavors.

🔬Professional Endeavors

Since joining Jamia Hamdard in 2016 as a Ph.D. Scholar, Kudsiya Ashrafi has made significant strides in her field. Her research expertise encompasses Plant Tissue Culture, genetic engineering, and molecular biology techniques. Over the past seven years, she has gained extensive experience in in vitro technologies, cloning, miRNAs, gene over-expression, and various analytical techniques such as HPTLC, GC-MS, and Confocal Microscopy. Her work includes developing improved transgenic varieties of medicinal plants, a testament to her commitment to advancing plant biotechnology.

🌿Contributions and Research Focus

Kudsiya’s research is notable for its focus on enhancing plant traits and secondary metabolite production. Her Ph.D. research on the functional characterization of miRstv_7 in Stevia rebaudiana aimed to improve steviol glycosides biosynthesis. By using miRNA interference, she developed a protocol for regenerating stevia plants with enhanced organoleptic and antioxidant properties. This innovative work led to her article being awarded the Dr. P.D. Sethi Memorial National Award for Best HPTLC Publication in 2022.Her contributions extend to other significant projects, including the germline transformation of Artemisia annua using the floral-dip method and profiling berberine biosynthesis in Tinospora cordifolia. She has also studied miRNAs in Indian Mustard (Brassica juncea), focusing on sulfur uptake and assimilation. Kudsiya’s research not only enhances our understanding of plant biotechnology but also contributes to practical applications in agriculture and medicine.

🏆Accolades and Recognition

Kudsiya Ashrafi’s research excellence has been recognized through multiple awards and accolades. Her research articles have been published in high-impact journals such as Industrial Crops and Products, ACS Omega, Plant Science, and PLOS ONE. She has received awards for her presentations at both national and international conferences, underscoring her contributions to the scientific community. Her success in qualifying prestigious exams like CSIR-UGC NET, DBT-JRF, ASRB NET, and CTET further highlights her academic prowess.

🌍Impact and Influence

Kudsiya’s work has significantly impacted the field of plant biotechnology. Her research on improving plant traits through genetic engineering and molecular biology has practical implications for crop enhancement and medicinal plant development. The protocols and methods she has developed are being utilized to create plants with better growth, yield, and secondary metabolite production. Her involvement in the scientific community, including her role as a life member of the Indian Science Congress Association and her participation in organizing academic conferences, demonstrates her influence beyond her research work.

🚀Legacy and Future Contributions

As Kudsiya Ashrafi continues her Ph.D. studies, her future contributions promise to further the field of plant biotechnology. Her ongoing research aims to refine transgenic technologies and enhance the secondary metabolite production of various crops. Her legacy will be defined by her innovative approaches to plant biotechnology and her commitment to advancing agricultural and medicinal plant research. With a strong foundation and a track record of impactful research, Kudsiya is poised to make continued strides in her field, driving future innovations and contributing to the global scientific community.Kudsiya Ashrafi’s journey in plant biotechnology is marked by significant achievements and a clear vision for future advancements. Her dedication, research expertise, and contributions to the field highlight her role as a leading scholar and innovator in plant biotechnology. 🌟

Citations

A total of 40 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         40
  • h-index           10
  • i10-index         3

Notable Publications 

  • Artemisinin Production Strategies for Industrial Scale: Current Progress and Future Directions
    • Authors: Qamar, F., Ashrafi, K., Singh, A., Dash, P.K., Abdin, M.Z.
    • Journal: Industrial Crops and Products
    • Year: 2024.
  • Regulatory Trends in Engineering Bioactive-Phytocompounds
    • Authors: Saifi, M., Ashrafi, K., Qamar, F., Abdin, M.Z.
    • Journal: Plant Science
    • Year: 2024.
  • Enhancement of Diterpenoid Steviol Glycosides by Co-overexpressing SrKO and SrUGT76G1 Genes in Stevia rebaudiana Bertoni
    • Authors: Nasrullah, N., Ahmad, J., Saifi, M., Ashrafi, K., Abdin, M.Z.
    • Journal: PLoS ONE
    • Year: 2023.
  • Insights into Pharmacological Potential of Apigenin through Various Pathways on a Nanoplatform in Multitude of Diseases
    • Authors: Waheed, A., Zameer, S., Ashrafi, K., Sultana, Y., Iqbal, Z.
    • Journal: Current Pharmaceutical Design
    • Year: 2023.
  • Germline Transformation of Artemisia annua L. Plant via In Planta Transformation Technology “Floral Dip”
    • Authors: Qamar, F., Khan, S., Ashrafi, K., Saifi, M., Abdin, M.Z.
    • Journal: Biotechnology Reports
    • Year: 2022.

Mudasir Bashir Gugjoo | Regenerative Medicine | Best Researcher Award

Published-on by Indian Scientist

Dr. Mudasir Bashir Gugjoo - Regenerative Medicine - Best Researcher Award 🏆 

Sher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir (SKUAST-K) - India

Professional Profiles

Early Academic Pursuits

He, currently serving as a Senior Assistant Professor at the Veterinary Clinical Complex in Srinagar, India, embarked on his academic journey with a fervent passion for veterinary medicine. He pursued his Bachelor of Veterinary Science and Animal Husbandry (BVSc & AH) from Shuhama, SKUAST-Kashmir, Jammu & Kashmir, India, laying a strong foundation for his future endeavors in the field of healthcare innovation.

Professional Endeavors

Over the years, he has ascended the ranks in academia and veterinary practice, contributing significantly to the realms of regenerative medicine, tissue engineering, and biomedical research. With a distinguished career spanning several roles, including Veterinary Assistant Surgeon, Senior Veterinary Officer, and now as a seasoned Assistant Professor, he has garnered invaluable experience and expertise in the application of advanced medical technologies and innovative treatment modalities.

Contributions and Research Focus in Regenerative Medicine

His research focuses primarily on the intersection of biomaterials and stem cells within the realm of regenerative medicine. His pioneering work includes the development and application of stem cell-loaded bioactive ceramics for bone tissue engineering, hydrogel technology for skin wound healing, and acellular corneal grafts for corneal ulcers. Through his establishment of a Stem Cell Laboratory at the Division of Veterinary Clinical Complex, FVSc & AH, Shuhama, under the SERB-DST project, he has spearheaded groundbreaking research initiatives aimed at advancing the field of regenerative medicine.

Accolades and Recognition

His exemplary contributions to the field of regenerative medicine have not gone unnoticed. He has received accolades such as the Best Researcher Award, acknowledging his outstanding achievements and dedication to advancing healthcare innovation. His research endeavors have been commended for their significant impact on veterinary medicine and the broader biomedical community.

Impact and Influence

His research has far-reaching implications, not only within the veterinary domain but also in human healthcare. By pioneering novel techniques and therapeutic approaches, such as evaluating nano-cement/stem cells for bone tissue engineering and natural bone decellularized matrix/stem cells for bone tissue regeneration, he has contributed to the development of transformative treatments with the potential to improve patient outcomes and quality of life.

Legacy and Future Contributions

As he continues to push the boundaries of scientific discovery in regenerative medicine, his legacy as a trailblazer in the field is firmly established. His commitment to excellence, coupled with his passion for advancing healthcare through innovative research and technological interventions, ensures that his contributions will continue to shape the future of regenerative medicine for years to come. With a steadfast dedication to making meaningful strides in healthcare innovation, he remains poised to leave an enduring legacy of impact and inspiration in the field of regenerative medicine and beyond.

Citations

  • Citations               1424
  • h-index                  22
  • i10-index               33

Notable Publications